These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21945218)

  • 1. Expanding and enhancing our antibacterial arsenal.
    Collins JJ; Donadio S
    Curr Opin Microbiol; 2011 Oct; 14(5):511-2. PubMed ID: 21945218
    [No Abstract]   [Full Text] [Related]  

  • 2. The antibiotic R&D pipeline: an update.
    Jabes D
    Curr Opin Microbiol; 2011 Oct; 14(5):564-9. PubMed ID: 21873107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postgenomic strategies in antibacterial drug discovery.
    Brötz-Oesterhelt H; Sass P
    Future Microbiol; 2010 Oct; 5(10):1553-79. PubMed ID: 21073314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing the frustrations of finding new effective antibacterials to combat drug resistant bacteria.
    Fernandes P; Pizza M
    Curr Opin Microbiol; 2008 Oct; 11(5):385-6. PubMed ID: 18804177
    [No Abstract]   [Full Text] [Related]  

  • 5. Antimicrobial resistance: no action today, no cure tomorrow.
    Sharma A
    Indian J Med Microbiol; 2011; 29(2):91-2. PubMed ID: 21654100
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibiotic discovery in the twenty-first century: current trends and future perspectives.
    Donadio S; Maffioli S; Monciardini P; Sosio M; Jabes D
    J Antibiot (Tokyo); 2010 Aug; 63(8):423-30. PubMed ID: 20551985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sources of novel antibiotics--aside the common roads.
    Donadio S; Maffioli S; Monciardini P; Sosio M; Jabes D
    Appl Microbiol Biotechnol; 2010 Dec; 88(6):1261-7. PubMed ID: 20865256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020.
    Infectious Diseases Society of America
    Clin Infect Dis; 2010 Apr; 50(8):1081-3. PubMed ID: 20214473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial drug development: challenges, recent developments, and future considerations.
    Nambiar S; Laessig K; Toerner J; Farley J; Cox E
    Clin Pharmacol Ther; 2014 Aug; 96(2):147-9. PubMed ID: 25056394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taking inventory: antibacterial agents currently at or beyond phase 1.
    Bush K; Macielag M; Weidner-Wells M
    Curr Opin Microbiol; 2004 Oct; 7(5):466-76. PubMed ID: 15451501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of broad-spectrum antibiofilm drugs: strategies and challenges.
    Dharmaprakash A; Thandavarayan R; Joseph I; Thomas S
    Future Microbiol; 2015; 10(6):1035-48. PubMed ID: 26059624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial drug discovery in the resistance era.
    Brown ED; Wright GD
    Nature; 2016 Jan; 529(7586):336-43. PubMed ID: 26791724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Aminothiazolyl analogues of GE2270 A: antibacterial lead finding.
    LaMarche MJ; Leeds JA; Dzink-Fox J; Gunderson K; Krastel P; Memmert K; Patane MA; Rann EM; Schmitt E; Tiamfook S; Wang B
    J Med Chem; 2011 Apr; 54(7):2517-21. PubMed ID: 21405087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whither antibacterial drug discovery?
    Projan SJ
    Drug Discov Today; 2008 Apr; 13(7-8):279-80. PubMed ID: 18405838
    [No Abstract]   [Full Text] [Related]  

  • 16. Coping with antibiotic resistance: the impending crisis.
    Gould IM
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 3():S1-2. PubMed ID: 21129626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradigm shift in discovering next-generation anti-infective agents: targeting quorum sensing, c-di-GMP signaling and biofilm formation in bacteria with small molecules.
    Sintim HO; Smith JA; Wang J; Nakayama S; Yan L
    Future Med Chem; 2010 Jun; 2(6):1005-35. PubMed ID: 21426116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When will the genomics investment pay off for antibacterial discovery?
    Mills SD
    Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antibacterial activity of 3-O-carbamoyl derivatives of 6,11-di-O-methylerythromycin A: a novel class of acylides.
    Wu Z; Lu Y; Luo M; He X; Xiao Y; Yang J; Pan Y; Qiu G; Guo H; Hu H; Zhou D; Hu X
    Eur J Med Chem; 2010 Sep; 45(9):3636-44. PubMed ID: 20554083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibacterial agents targeting bacterial cytoskeletal proteins].
    Wachi M; Iwai N
    Tanpakushitsu Kakusan Koso; 2008 Oct; 53(13):1765-70. PubMed ID: 19044290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.